Related posts: BioVantra Partners with Lumea Lumea and Invitae Partner to Advance Genetic Test Access Introducing PathPulse: Pathology Innovators in Action Podcast Lumea Announces Availability of Cxbladder™ Tests on BxLink™…
Related posts: Verily and Lumea Announce Development Partnership Alphabet’s Life Sciences Arm is Partnering with Lumea Lumea Announces Presenters for the 2022 Digital Diagnostic Summit BioVantra Partners with Lumea
Digital pathology has recently been transformed by emerging advanced technology, creating new opportunities for practices. While many still hesitate to take the plunge and adopt digital pathology, the benefits cannot…
Related posts: Top 10 Things to Consider When Choosing a Computer for Digital Pathology Prostate BxChip® Saves Lab $75 per Patient and Reduces Pathologist time by 50% Is Digital Pathology Faster…
BioVantra is an early adopter of digital pathology. Digital pathology is digitizing glass slides using a whole slide image scanner and then analyzing the digital images using an image viewer,…
Lumea is putting on the first conference of its kind: The Digital Diagnostic Summit. It focuses on the practical deployment of digital diagnostic technologies in the pathology office, the clinic,…
Following in the footsteps of radiology, its brother in imaging analysis arms, digital pathology has recently become a popular canvas for artificial intelligence applications. Startups like Ibex, previous Fierce 15…
HIT Consultant highlighted the Lumea and Verily strategic partnership on their website. What You Should Know: – Verily and Lumea announced a strategic partnership today to develop products. These products…
LEHI, UT, and SOUTH SAN FRANCISCO, CA – March 16, 2022—Lumea, the global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, today announced a strategic…
Related posts: The Lumea BxChip® Saves Labs Time, Money, and Improves Quality Digital Pathology is Becoming a Popular Canvas for AI Applications Artificial Intelligence In Digital Pathology – Podcast Three…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
